TY  - CONF
AU  - Bekčić, Stana
AU  - Mitrović, I.
AU  - Baltezarević, D.
AU  - Radojević, V.
AU  - Samardžić, J.
AU  - Milenković, V.
PY  - 2014
UR  - http://intor.torlakinstitut.com/handle/123456789/408
PB  - Elsevier Science Inc, New York
C3  - Value in Health
T1  - Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer
EP  - A654
IS  - 7
SP  - A654
VL  - 17
DO  - 10.1016/j.jval.2014.08.2385
ER  - 

@conference{
author = "Bekčić, Stana and Mitrović, I. and Baltezarević, D. and Radojević, V. and Samardžić, J. and Milenković, V.",
year = "2014",
url = "http://intor.torlakinstitut.com/handle/123456789/408",
publisher = "Elsevier Science Inc, New York",
journal = "Value in Health",
title = "Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer",
pages = "A654-A654",
number = "7",
volume = "17",
doi = "10.1016/j.jval.2014.08.2385"
}

Bekčić, S., Mitrović, I., Baltezarević, D., Radojević, V., Samardžić, J.,& Milenković, V. (2014). Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer.
Value in Health
Elsevier Science Inc, New York., 17(7), A654-A654.
https://doi.org/10.1016/j.jval.2014.08.2385

Bekčić S, Mitrović I, Baltezarević D, Radojević V, Samardžić J, Milenković V. Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer. Value in Health. 2014;17(7):A654-A654

Bekčić Stana, Mitrović I., Baltezarević D., Radojević V., Samardžić J., Milenković V., "Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer" Value in Health, 17, no. 7 (2014):A654-A654,
https://doi.org/10.1016/j.jval.2014.08.2385 .